{"id":7139,"date":"2019-08-13T10:44:09","date_gmt":"2019-08-13T08:44:09","guid":{"rendered":"https:\/\/inovie.fr\/inopath-v2\/?p=7139"},"modified":"2020-06-16T11:06:17","modified_gmt":"2020-06-16T09:06:17","slug":"la-has-recommande-le-test-hpv-comme-depistage-primaire-du-cancer-du-col-de-luterus-pour-les-femmes-a-partir-de-30-ans","status":"publish","type":"post","link":"https:\/\/inopath.fr\/2019\/08\/13\/la-has-recommande-le-test-hpv-comme-depistage-primaire-du-cancer-du-col-de-luterus-pour-les-femmes-a-partir-de-30-ans\/","title":{"rendered":"Recommandations de l’HAS pour le test HPV"},"content":{"rendered":"

La HAS recommande le test HPV comme d\u00e9pistage primaire du cancer du col de l’ut\u00e9rus pour les femmes \u00e0 partir de 30 ans.<\/strong><\/p>\n

La Direction G\u00e9n\u00e9rale de la Sant\u00e9 a sollicit\u00e9 la Haute Autorit\u00e9 de Sant\u00e9 pour \u00e9valuer la place du test HPV ainsi que le recours au double immuno-marquage p16\/Ki67<\/strong> dans la strat\u00e9gie de d\u00e9pistage primaire des l\u00e9sions pr\u00e9-canc\u00e9reuses et canc\u00e9reuses du cancer du col de l’ut\u00e9rus.<\/p>\n

Suite \u00e0 cette \u00e9valuation, voici les nouvelles recommandations de l’HAS<\/span>:<\/p>\n

– Maintien des modalit\u00e9s de d\u00e9pistage du cancer du col de l’ut\u00e9rus et des strat\u00e9gies de triage pour les femmes \u00e2g\u00e9es de 25 \u00e0 30 ans<\/strong>: pour ces derni\u00e8res,\u00a0 le d\u00e9pistage du cancer du col de l’ut\u00e9rus reste fond\u00e9 sur la r\u00e9alisation de deux examens cytologiques \u00e0 1 an d’intervalle, puis 3 ans apr\u00e8s si le r\u00e9sultat des deux premiers est normal.<\/p>\n

– \u00c9volution des modalit\u00e9s de d\u00e9pistage du cancer du col de l’ut\u00e9rus pour les femmes \u00e2g\u00e9es de 30 \u00e0 65 ans:<\/strong> la HAS recommande que le test HPV remplace l’examen cytologique en d\u00e9pistage primaire du cancer du col de l’ut\u00e9rus. Ce test sera r\u00e9alis\u00e9 3 ans apr\u00e8s le dernier examen cytologique dont le r\u00e9sultat \u00e9tait normal ; le rythme entre deux d\u00e9pistages par test HPV est de 5 ans, d\u00e8s lors que le r\u00e9sultat du test est n\u00e9gatif.<\/p>\n

– Strat\u00e9gie de triage des femmes ayant un test HPV positif<\/strong>: pour les femmes \u00e2g\u00e9es de 30 \u00e0 65 ans, auxquelles un test HPV a \u00e9t\u00e9 propos\u00e9, une strat\u00e9gie de triage en 2 temps est recommand\u00e9.<\/p>\n

– Place du double immuno-marquage p16\/Ki67 dans la strat\u00e9gie de d\u00e9pistage du cancer du col de l’ut\u00e9rus<\/strong>: l’utilisation du double immuno-marquage p16\/Ki67 en d\u00e9pistage primaire ou comme test de triage apr\u00e8s un test HPV n’est pas recommand\u00e9e.<\/p>\n

Pour lire enti\u00e8rement la synth\u00e8se de la recommandation en sant\u00e9 publique de la HAS : Synth\u00e8se recommandation HAS<\/em><\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

La HAS recommande le test HPV comme d\u00e9pistage primaire du cancer du col de l’ut\u00e9rus pour les femmes \u00e0 partir de 30 ans. La Direction G\u00e9n\u00e9rale de la Sant\u00e9 a sollicit\u00e9 la Haute Autorit\u00e9 de Sant\u00e9 pour \u00e9valuer la place … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":21,"featured_media":7143,"comment_status":"closed","ping_status":"closed","sticky":true,"template":"","format":"standard","meta":{"inline_featured_image":false,"_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"acf":[],"yoast_head":"\nRecommandations de l'HAS pour le test HPV - Inopath<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/inopath.fr\/2019\/08\/13\/la-has-recommande-le-test-hpv-comme-depistage-primaire-du-cancer-du-col-de-luterus-pour-les-femmes-a-partir-de-30-ans\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Recommandations de l'HAS pour le test HPV - Inopath\" \/>\n<meta property=\"og:description\" content=\"La HAS recommande le test HPV comme d\u00e9pistage primaire du cancer du col de l’ut\u00e9rus pour les femmes \u00e0 partir de 30 ans. La Direction G\u00e9n\u00e9rale de la Sant\u00e9 a sollicit\u00e9 la Haute Autorit\u00e9 de Sant\u00e9 pour \u00e9valuer la place … Continue reading →\" \/>\n<meta property=\"og:url\" content=\"https:\/\/inopath.fr\/2019\/08\/13\/la-has-recommande-le-test-hpv-comme-depistage-primaire-du-cancer-du-col-de-luterus-pour-les-femmes-a-partir-de-30-ans\/\" \/>\n<meta property=\"og:site_name\" content=\"Inopath\" \/>\n<meta property=\"article:published_time\" content=\"2019-08-13T08:44:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-06-16T09:06:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/inopath.fr\/wp-content\/uploads\/sites\/57\/2019\/08\/HAS.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"910\" \/>\n\t<meta property=\"og:image:height\" content=\"477\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Labosud Groupe Communication\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Labosud Groupe Communication\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/inopath.fr\/2019\/08\/13\/la-has-recommande-le-test-hpv-comme-depistage-primaire-du-cancer-du-col-de-luterus-pour-les-femmes-a-partir-de-30-ans\/\",\"url\":\"https:\/\/inopath.fr\/2019\/08\/13\/la-has-recommande-le-test-hpv-comme-depistage-primaire-du-cancer-du-col-de-luterus-pour-les-femmes-a-partir-de-30-ans\/\",\"name\":\"Recommandations de l'HAS pour le test HPV - Inopath\",\"isPartOf\":{\"@id\":\"https:\/\/inopath.fr\/#website\"},\"datePublished\":\"2019-08-13T08:44:09+00:00\",\"dateModified\":\"2020-06-16T09:06:17+00:00\",\"author\":{\"@id\":\"https:\/\/inopath.fr\/#\/schema\/person\/49006d15238e00543cff98db08aaf206\"},\"breadcrumb\":{\"@id\":\"https:\/\/inopath.fr\/2019\/08\/13\/la-has-recommande-le-test-hpv-comme-depistage-primaire-du-cancer-du-col-de-luterus-pour-les-femmes-a-partir-de-30-ans\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/inopath.fr\/2019\/08\/13\/la-has-recommande-le-test-hpv-comme-depistage-primaire-du-cancer-du-col-de-luterus-pour-les-femmes-a-partir-de-30-ans\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/inopath.fr\/2019\/08\/13\/la-has-recommande-le-test-hpv-comme-depistage-primaire-du-cancer-du-col-de-luterus-pour-les-femmes-a-partir-de-30-ans\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/inopath.fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Recommandations de l’HAS pour le test HPV\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/inopath.fr\/#website\",\"url\":\"https:\/\/inopath.fr\/\",\"name\":\"Inopath\",\"description\":\"P\u00f4le d\u2019excellence en anatomopathologie\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/inopath.fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/inopath.fr\/#\/schema\/person\/49006d15238e00543cff98db08aaf206\",\"name\":\"Labosud Groupe Communication\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/inopath.fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/41dce42773c69f757749bb4e4d657217?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/41dce42773c69f757749bb4e4d657217?s=96&d=mm&r=g\",\"caption\":\"Labosud Groupe Communication\"},\"sameAs\":[\"http:\/\/labosud.com\"],\"url\":\"https:\/\/inopath.fr\/author\/labosud-groupe\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Recommandations de l'HAS pour le test HPV - Inopath","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/inopath.fr\/2019\/08\/13\/la-has-recommande-le-test-hpv-comme-depistage-primaire-du-cancer-du-col-de-luterus-pour-les-femmes-a-partir-de-30-ans\/","og_locale":"fr_FR","og_type":"article","og_title":"Recommandations de l'HAS pour le test HPV - Inopath","og_description":"La HAS recommande le test HPV comme d\u00e9pistage primaire du cancer du col de l’ut\u00e9rus pour les femmes \u00e0 partir de 30 ans. La Direction G\u00e9n\u00e9rale de la Sant\u00e9 a sollicit\u00e9 la Haute Autorit\u00e9 de Sant\u00e9 pour \u00e9valuer la place … Continue reading →","og_url":"https:\/\/inopath.fr\/2019\/08\/13\/la-has-recommande-le-test-hpv-comme-depistage-primaire-du-cancer-du-col-de-luterus-pour-les-femmes-a-partir-de-30-ans\/","og_site_name":"Inopath","article_published_time":"2019-08-13T08:44:09+00:00","article_modified_time":"2020-06-16T09:06:17+00:00","og_image":[{"width":910,"height":477,"url":"https:\/\/inopath.fr\/wp-content\/uploads\/sites\/57\/2019\/08\/HAS.jpg","type":"image\/jpeg"}],"author":"Labosud Groupe Communication","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Labosud Groupe Communication","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/inopath.fr\/2019\/08\/13\/la-has-recommande-le-test-hpv-comme-depistage-primaire-du-cancer-du-col-de-luterus-pour-les-femmes-a-partir-de-30-ans\/","url":"https:\/\/inopath.fr\/2019\/08\/13\/la-has-recommande-le-test-hpv-comme-depistage-primaire-du-cancer-du-col-de-luterus-pour-les-femmes-a-partir-de-30-ans\/","name":"Recommandations de l'HAS pour le test HPV - Inopath","isPartOf":{"@id":"https:\/\/inopath.fr\/#website"},"datePublished":"2019-08-13T08:44:09+00:00","dateModified":"2020-06-16T09:06:17+00:00","author":{"@id":"https:\/\/inopath.fr\/#\/schema\/person\/49006d15238e00543cff98db08aaf206"},"breadcrumb":{"@id":"https:\/\/inopath.fr\/2019\/08\/13\/la-has-recommande-le-test-hpv-comme-depistage-primaire-du-cancer-du-col-de-luterus-pour-les-femmes-a-partir-de-30-ans\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/inopath.fr\/2019\/08\/13\/la-has-recommande-le-test-hpv-comme-depistage-primaire-du-cancer-du-col-de-luterus-pour-les-femmes-a-partir-de-30-ans\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/inopath.fr\/2019\/08\/13\/la-has-recommande-le-test-hpv-comme-depistage-primaire-du-cancer-du-col-de-luterus-pour-les-femmes-a-partir-de-30-ans\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/inopath.fr\/"},{"@type":"ListItem","position":2,"name":"Recommandations de l’HAS pour le test HPV"}]},{"@type":"WebSite","@id":"https:\/\/inopath.fr\/#website","url":"https:\/\/inopath.fr\/","name":"Inopath","description":"P\u00f4le d\u2019excellence en anatomopathologie","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/inopath.fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/inopath.fr\/#\/schema\/person\/49006d15238e00543cff98db08aaf206","name":"Labosud Groupe Communication","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/inopath.fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/41dce42773c69f757749bb4e4d657217?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/41dce42773c69f757749bb4e4d657217?s=96&d=mm&r=g","caption":"Labosud Groupe Communication"},"sameAs":["http:\/\/labosud.com"],"url":"https:\/\/inopath.fr\/author\/labosud-groupe\/"}]}},"_links":{"self":[{"href":"https:\/\/inopath.fr\/wp-json\/wp\/v2\/posts\/7139"}],"collection":[{"href":"https:\/\/inopath.fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/inopath.fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/inopath.fr\/wp-json\/wp\/v2\/users\/21"}],"replies":[{"embeddable":true,"href":"https:\/\/inopath.fr\/wp-json\/wp\/v2\/comments?post=7139"}],"version-history":[{"count":7,"href":"https:\/\/inopath.fr\/wp-json\/wp\/v2\/posts\/7139\/revisions"}],"predecessor-version":[{"id":7523,"href":"https:\/\/inopath.fr\/wp-json\/wp\/v2\/posts\/7139\/revisions\/7523"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/inopath.fr\/wp-json\/wp\/v2\/media\/7143"}],"wp:attachment":[{"href":"https:\/\/inopath.fr\/wp-json\/wp\/v2\/media?parent=7139"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/inopath.fr\/wp-json\/wp\/v2\/categories?post=7139"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/inopath.fr\/wp-json\/wp\/v2\/tags?post=7139"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}